Research Antibodies Market Size, Share & Trend Report

Research Antibodies Market Size, Share & Trend Analysis Report By Product (Primary Antibodies), By Type (Monoclonal Antibodies), By Technology, By Source, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-124-5
  • Number of Pages: 130
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the research antibodies market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for research antibodies market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of research antibodies market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Research Antibodies Market Categorization:

The research antibodies market was categorized into seven segments, namely product (Primary Antibodies, Secondary Antibodies), type (Monoclonal Antibodies, Polyclonal Antibodies), technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA), source (Mouse, Rabbit, Goat), application (Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology), end-use (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The research antibodies market was segmented into product, type, technology, source, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The research antibodies market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-four countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; India; Japan; Australia; Thailand; South Korea; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Research antibodies market companies & financials:

The research antibodies market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Abcam plc is a company specializing in the production and marketing of protein research tools. This company is useful in the field of diagnostics, drug discovery, and other research work. Its product segment includes antibodies, research-grade antibodies, IVD antibodies, antagonists, activators, and inhibitors, and proteins & peptides. Abcam serves more than 130 countries globally and is headquartered in the UK, with 11 additional centers in the U.S., Asia, and other parts of UK.

  • Bio-Rad Laboratories Inc. develops and manufactures systems and products used in separating complex biological and chemical materials, as well as to analyze, identify, and purify their respective components. In clinical diagnostics segment, the company designs, manufactures, supports, and sell informatics systems, test systems, quality controls, and test kits. These products serve clinical laboratories in the global market. The company’s diagnostic products consist of a range of technologies and aims at delivering high value clinical information. Similarly, life sciences segment aims at creating and discovering tools, required in biological processes. The company develops, manufactures and markets apparatus, reagents, and laboratory instruments, which are used exclusively in the process of biopharmaceutical production, research techniques, and food testing regimes. Key end-users of Bio-Rad products include hospitals, research institutions, laboratories, biotechnology companies, and pharmaceutical firms.

  • BD (Becton Dickinson & Company) is an American medical technology firm that develops, produces, and sells medical devices, laboratory equipment, and medical supplies. The medical segment provides catheters, needle free connectors, extension sets, fluids, drug transfer diseases, hazardous drug detection, anesthesia needles, disposal systems, dedicated disposables, infusion pumps, automated medication dispensing, products for diabetes care. The Life Science segment provides specimen & blood collection systems and products, automated blood and tuberculosis culturing, microorganism detection, molecular testing, rapid diagnostic assays, monitoring reagents and analyzers. The company operates in more than 50 countries across the globe.

  • Merck Millipore is a provider of a wide range of pharmaceutical and chemical products catering various industries. This company operates through three business sectors i.e., healthcare, life science and performance materials. The company offers life science products and services for drug discovery and development along with research and laboratory applications. It also provides prescription medicines for the treatment of multiple sclerosis, colorectal cancer, diabetes, cardiovascular diseases, infertility and others. The company also provides over the counter medicines, probiotic supplements and various other products for women’s health and nutrition. It has strategic collaborations with companies such as Pfizer, Intrexon Corporation, and Bristol-Myers Squibb. The company operates in over 66 countries globally.

  • Lonza caters to pharmaceutical, consumer health, biotech, and specialty ingredients industries. Lonza develops preventive and curative medicines, nutritional ingredients, and personal care products. The company operates through two business segments—Pharma & Biotech and Specialty Ingredients. The former segment includes chemical and biologics division along with bioscience solutions and capsule delivery solutions business units. The Specialty Ingredients segment includes consumer health division, consumer & resources protection division, and water care business unit. The company supplies its products to about 30 countries across the globe and has approximately 53 manufacturing and R&D facilities.

  • Thermo Fisher Scientific Inc. is a manufacturer and provider of laboratory reagents and equipment, analytical instruments, software, reagents, instrument systems, chemicals, consumables and diagnostic products. The company services and supplies through premier brands such as Thermo Scientific, Fisher Scientific, Applied Biosystems, and Invitrogen. The company’s life science solutions segment offers reagents, consumables, and instruments for biological and medical research, discovery and production of new drugs and vaccines and also diagnosis of diseases catering to pharmaceutical, biotechnology, agricultural, clinical and academic as well as government markets. Its Analytical Instrument segment provides equipment’s and instruments along with consumables and services which have various applications on the production line, laboratory and on the field. Its Solutions segment provides instruments and reagents & consumables that are used in diagnosis of diseases, medical & biological research as well as in the discovery of new drugs and vaccines.

  • Cell Signaling Technology is a private company specializing in the development of antibody products for clinical diagnostics and medical research markets. Its products include primary antibodies, antibody sampler, secondary antibodies, antibody conjugates, ELISA kits, proteomic kits, and many others. It also provides custom antibody conjugation and proteomic services. This company has its offices located in Japan, China, and the Netherlands.

  • F. Hoffmann-La Roche Ltd. is a multinational healthcare company operating under two segments: Diagnostics and Pharmaceuticals. The company has expertise in drugs for cancer and transplantation, virology, metabolism, inflammation, clinical chemistry, CNS, immunology, blood screening, urinalysis, infectious diseases, microbiology and genetics. The company is also into research, development, and production of molecular diagnostic reagents, test kits and test systems and provides automated instruments, software, IT solutions and consumables which are extensively used in in-vitro research and diagnostics. It is presently operating as a subsidiary of Roche Holding AG in over 100 countries.

  • Agilent Technologies, Inc. is involved in developing, manufacturing, and research that provides application focused solutions to the diagnostics, life sciences, and applied chemical markets globally. It operates through three segments: Diagnostics, Agilent CrossLab, Applied science market, Life sciences market and Genomics. The company serves routine and clinical diagnostics markets and analytical laboratories with varied technology platforms such as bio reagents, automation, FISH probes, liquid chromatography, informatics, immunohistochemistry, microarrays, mass spectrometry, vacuum technologies and others.

  • PerkinElmer, Inc., is an American company that offers products, solutions, and services to the life sciences, diagnostics, and applied services market. The company majorly operates in two segments – diagnostics & discovery, and analytical solutions. The analytical solutions segment offer product such as reagents, detection and imaging technologies and informatics that help scientists to enhance research in life sciences research & laboratory services market. It also provides analytical solutions, technologies, and services for food, environmental and industrial markets. The diagnostics segment offers instruments, software products, reagents that is used for early detection of genetic disorders and infectious disease testing. Products of this segment can also be used for screening and testing genetic abnormalities, diseases and disorders that include hypothyroidism, Down syndrome, infertility, and other metabolic diseases. The company serves biotechnological and pharmaceutical companies, clinical research institutions, private health organizations, doctors, public health authorities, and government agencies.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Research Antibodies Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Research Antibodies Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon